Polycystic ovary syndrome

被引:1256
作者
Norman, Robert J.
Dewailly, Didier
Legro, Richard S.
Hickey, Theresa E.
机构
[1] Univ Adelaide, Sch Paediat & Reprod Hlth, Res Ctr Reprod Hlth, Adelaide, SA, Australia
[2] Ctr Hosp Lille, Hop Jeanne Flandre, Dept Endocrine Gynaecol & Reprod Med, Lille, France
[3] Penn State Coll Med, Milton S Hershey Med Ctr, Dept Obstet & Gynecol, Hershey, PA USA
关键词
D O I
10.1016/S0140-6736(07)61345-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects about one in 15 women worldwide. The major endocrine disruption is excessive androgen secretion or activity; and a large proportion of women also have abnormal insulin activity. Many body systems are affected in polycystic ovary syndrome, resulting in several health complications, including menstrual dysfunction, infertility; hirsutism, acne, obesity and metabolic syndrome. Women with this disorder have an established increased risk of developing type 2 diabetes and a still debated increased risk of cardiovascular disease. The diagnostic traits of polycystic ovary syndrome are hyperandrogenism, chronic anovulation, and polycystic ovaries, after exclusion of other conditions that cause these same features. A conclusive definition of the disorder and the importance of the three diagnostic criteria relative to each other remain controversial. The cause of polycystic ovary syndrome is unknown, but studies suggest a strong genetic component that is affected by gestational environment, lifestyle factors, or both.
引用
收藏
页码:685 / 697
页数:13
相关论文
共 182 条
[1]   Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? [J].
Abbott, DH ;
Barnett, DK ;
Bruns, CM ;
Dumesic, DA .
HUMAN REPRODUCTION UPDATE, 2005, 11 (04) :357-374
[2]  
ADAMS J, 1985, LANCET, V2, P1375
[3]   INSULIN ENHANCEMENT OF LUTEINIZING-HORMONE AND FOLLICLE-STIMULATING-HORMONE RELEASE BY CULTURED PITUITARY-CELLS [J].
ADASHI, EY ;
HSUEH, AJW ;
YEN, SSC .
ENDOCRINOLOGY, 1981, 108 (04) :1441-1449
[4]  
ADASHI EY, 1981, FERTIL STERIL, V36, P320
[5]   The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[6]   A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain [J].
Asunción, M ;
Calvo, RM ;
San Millán, JL ;
Sancho, J ;
Avila, S ;
Escobar-Morreale, HF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2434-2438
[7]  
Ayala C, 1999, Endocr Pract, V5, P322
[8]   Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature [J].
Azziz, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03) :781-785
[9]   Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span [J].
Azziz, R ;
Marin, C ;
Hoq, L ;
Badamgarav, E ;
Song, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (08) :4650-4658
[10]   The prevalence and features of the polycystic ovary syndrome in an unselected population [J].
Azziz, R ;
Woods, KS ;
Reyna, R ;
Key, TJ ;
Knochenhauer, ES ;
Yildiz, BO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2745-2749